Johnson & Johnson Innovation Catalyzes New and Exciting Science and Technology in Pharmaceutical, Medical Device, Diagnostic and Consumer Healthcare Spaces

On June 19, 2014 Johnson & Johnson Innovation, LLC reported that Janssen Biotech, Inc. and Johnson & Johnson Innovation have formed a research collaboration with Weill Cornell Medical College aimed at developing compounds for targeting the function of a lymphoma causing protein (Press release Johnson & Johnson, JUN 19, 2014, View Source [SID:1234500594]). Through the collaboration, investigators at Weill Cornell and Janssen drug development researchers will collaborate to discover, validate and characterize inhibitors of the protein and further elucidate novel targeting methods.